Literature DB >> 20395031

Hypothermia improves ventricular myocyte contractility under conditions of normal perfusion and after an interval of ischemia.

Giuseppe Ristagno1, Simona Tantillo, Shijie Sun, Max Harry Weil, Wanchun Tang.   

Abstract

AIM: Recent investigations have reported improved myocardial function during hypothermia following resuscitation from cardiac arrest. The effects of hypothermia on myocyte contractility were investigated under conditions of normal perfusion and after a 10min interval of ischemia.
METHODS: Ventricular myocytes were obtained from 10 male Sprague-Dawley rats weighing 400+/-50g. The myocytes were randomized to be perfused at: 37 degrees C, 34 degrees C, 32 degrees C, or 30 degrees C. A subsequent set of myocytes was subjected to 10min of ischemia at 37 degrees C, prior to being randomized to reperfusion at: 37 degrees C, 34 degrees C, 32 degrees C or 30 degrees C. Myocyte contractility was expressed as length-shortening percentage. Intracellular Ca(2+) transients were assessed in a separate group of myocytes preloaded with Fura-2/AM. Sensitivity to Ca(2+) was tested by increasing perfusate Ca(2+) content, i.e. 0.5mM, 1mM and 2mM.
RESULTS: During normal perfusion and following reperfusion after 10min of ischemia, myocyte contractility increased at 34 degrees C compared to 37 degrees C (P<0.01). When the perfusion temperature was decreased to 32 degrees C and 30 degrees C, contractility further increased (P<0.001). Intracellular Ca(2+) transients were greater during perfusion at 34 degrees C compared to those at 37 degrees C (P<0.001) and further increased at 30 degrees C (P<0.001). Increases in extracellular Ca(2+) concentration from 0.5mM to 2mM resulted in greater myocyte contractility during perfusion at 30 degrees C compared to that observed at 37 degrees C (P<0.001). Effects of hypothermia on intracellular Ca(2+) transients and sensitivity to Ca(2+) persisted after ischemia.
CONCLUSIONS: Hypothermia improved myocyte contractility, intracellular Ca(2+) transients and sensitivity to Ca(2+) under conditions of normal perfusion and following reperfusion after 10min of ischemia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20395031     DOI: 10.1016/j.resuscitation.2010.03.016

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  7 in total

1.  Ischemia hypothermia improved contractility under normothermia reperfusion in the model of cultured cardiomyocyte.

Authors:  Heng Li; Xiangshao Fang; Zhengfei Yang; Yue Fu; Yu Wang; Jinlang Wu; Tao Yu; Zitong Huang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-04-26       Impact factor: 2.416

2.  Lipid emulsion rapidly restores contractility in stunned mouse cardiomyocytes: a comparison with therapeutic hypothermia.

Authors:  Jing Li; Michael Fettiplace; Sy-Jou Chen; Benjamin Steinhorn; Zuohui Shao; Xiangdong Zhu; Changqing Li; Shaun Harty; Guy Weinberg; Terry L Vanden Hoek
Journal:  Crit Care Med       Date:  2014-12       Impact factor: 7.598

Review 3.  Intra-arrest hypothermia during cardiac arrest: a systematic review.

Authors:  Sabino Scolletta; Fabio Silvio Taccone; Per Nordberg; Katia Donadello; Jean-Louis Vincent; Maaret Castren
Journal:  Crit Care       Date:  2012-12-12       Impact factor: 9.097

4.  Targeted Temperature Management (TTM 2014).

Authors: 
Journal:  BMC Emerg Med       Date:  2015-06-24

5.  Of ions and temperature: the complicated interplay of temperature, fluids, and electrolytes on myocardial function.

Authors:  Kees H Polderman
Journal:  Crit Care       Date:  2013-12-04       Impact factor: 9.097

6.  Mild Hypothermia May Offer Some Improvement to Patients with MODS after CPB Surgery.

Authors:  Xiaoqi Zhao; Tianxiang Gu; Zongyi Xiu; Enyi Shi; Lei Yu
Journal:  Braz J Cardiovasc Surg       Date:  2016 May-Jun

7.  Hypothermia improves oral and gastric mucosal microvascular oxygenation during hemorrhagic shock in dogs.

Authors:  Christian Vollmer; Ingo Schwartges; Meike Swertz; Christopher Beck; Inge Bauer; Olaf Picker
Journal:  Oxid Med Cell Longev       Date:  2013-11-12       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.